Hidoc Dr | Medical Learning App for Doctors

Today's Updates

Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA Frank C. Sciurba, MD

Published Date: 30 Oct 2026

Frank Sciurba, MD, reports tozorakimab improved E-RS:COPD scores vs placebo at week 52 in OBERON and TITANIA, including breathlessness and chest symptoms.

Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD

Published Date: 30 Oct 2026

Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD

Joanna Wardlaw, MD, on Biomarkers, Repurposed Drugs, and the Future of Small Vessel Disease Treatment Marco Meglio

Published Date: 30 Oct 2026

Joanna Wardlaw, MD, Professor of Applied Neuroimaging at the University of Edinburgh, discusses the evolving understanding of cerebral small vessel disease, emerging therapeutic approaches, and the makings behind a successful trial.

Collective Advocacy, Shared Priorities, and What’s Ahead at MDA 2027 Marco Meglio, Paul Melmeyer, MPP

Published Date: 30 Oct 2026

Paul Melmeyer, MPP, Executive Vice President of Public Policy and Advocacy at the Muscular Dystrophy Association, discusses the Neuromuscular Advocacy Collaborative, its growing year-round presence, and what the group hopes to accomplish heading into the 2027 MDA Clinical and Scientific Conference.

NeuroVoices: Bruce Ovbiagele, MD, MSc, MAS, MBA, on the Future of Stroke Publishing Marco Meglio, Bruce Ovbiagele, MD, MSc, MAS, MBA

Published Date: 30 Oct 2026

The Editor-in-Chief of the Journal of the American Heart Association discussed what journal editors look for in stroke research submissions, how AI and open access are reshaping publishing, and the equity gaps that still exist for researchers in lower-income countries.

Brain Chat: Migraine: More Than Just a Headache Mitzi Joi Williams, MD

Published Date: 30 Oct 2026

Mitzi Joi Williams, MD, is joined by Temitope Adeola, MD, and Chantale Branson, MD, to discuss migraine as a complex neurological condition, including recognizing symptoms and triggers, navigating acute and preventive treatment options, and incorporating lifestyle modifications to improve migraine management.

Why Patients Miss Dialysis Treatments, With Steven Brunelli, MD Steven Brunelli, MD

Published Date: 30 Oct 2026

A Kidney Week 2026 survey examines why patients miss dialysis, when barriers arise, and how outreach relates to rescheduling.

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

Published Date: 30 Oct 2026

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

Published Date: 30 Oct 2026

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

RLS-1496 Cream Reduces Actinic Keratosis Lesions Mary Spellman, MD

Published Date: 30 Oct 2026

Topical GPX4 inhibitor RLS-1496 1% reduced AK lesion counts by 43.5% vs 11.3% with untreated control at Day 57, with no application site reactions.

Knowledge Hub

Oncology

Tumor Metabolic Waste Products as Markers of Treatment Adaptation

A medical review of tumor-derived metabolic waste products as dynamic biomarkers for treatment response, resistance, toxicity, and therapeutic adaptation.

Oncology

Coordinating Supportive Care During Cancer Treatment Breaks

A clinical review of multidisciplinary strategies for maintaining symptom control, safety, function, and continuity during cancer treatment breaks.

Oncology

Pediatric Cancer Cell Line Authentication and Reproducibility

A practical scientific review of pediatric cancer cell-line authentication, contamination control, reproducibility, and translational quality standards.

Oncology

Case-Based Learning: Fever During Targeted Cancer Therapy Without Infection

A practical evidence-based review of evaluating and managing noninfectious fever during targeted cancer therapy while protecting patients from missed infection.

Oncology

KOL Videos

Hidoc Dr| Hidoc- US| Hidoc - Doctor Netwoking Platform| Educational resource for HCPs

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug Database Drug Interaction Diseases Database

KOL Videos Knowledge Hub Quizzes

Medical Updates Events About Us

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA Frank C. Sciurba, MD

Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD

Joanna Wardlaw, MD, on Biomarkers, Repurposed Drugs, and the Future of Small Vessel Disease Treatment Marco Meglio

Collective Advocacy, Shared Priorities, and What’s Ahead at MDA 2027 Marco Meglio, Paul Melmeyer, MPP

NeuroVoices: Bruce Ovbiagele, MD, MSc, MAS, MBA, on the Future of Stroke Publishing Marco Meglio, Bruce Ovbiagele, MD, MSc, MAS, MBA

Brain Chat: Migraine: More Than Just a Headache Mitzi Joi Williams, MD

Why Patients Miss Dialysis Treatments, With Steven Brunelli, MD Steven Brunelli, MD

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

RLS-1496 Cream Reduces Actinic Keratosis Lesions Mary Spellman, MD

Knowledge Hub

Tumor Metabolic Waste Products as Markers of Treatment Adaptation

Coordinating Supportive Care During Cancer Treatment Breaks

Pediatric Cancer Cell Line Authentication and Reproducibility

Case-Based Learning: Fever During Targeted Cancer Therapy Without Infection

Tumor Clonal Evolution Through Single-Cell Genomics

Mechanisms of Tumor Metabolic Plasticity During Nutrient Stress

RNA Vaccines for Therapeutic Oncology: Mechanisms, Clinical Applications, and Future Directions

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Page Views

Your one-stop Solution for MEDICAL LEARNING & UPDATES

Tozorakimab Improves Daily Respiratory Symptoms in COPD: OBERON, TITANIA Frank C. Sciurba, MD

Earlier PH Screening in ILD: PHINDER Data, With Parth Rali, MD

Joanna Wardlaw, MD, on Biomarkers, Repurposed Drugs, and the Future of Small Vessel Disease Treatment Marco Meglio

Collective Advocacy, Shared Priorities, and What’s Ahead at MDA 2027 Marco Meglio, Paul Melmeyer, MPP

NeuroVoices: Bruce Ovbiagele, MD, MSc, MAS, MBA, on the Future of Stroke Publishing Marco Meglio, Bruce Ovbiagele, MD, MSc, MAS, MBA

Brain Chat: Migraine: More Than Just a Headache Mitzi Joi Williams, MD

Why Patients Miss Dialysis Treatments, With Steven Brunelli, MD Steven Brunelli, MD

GLP-1s Tied to Weight Loss in Peritoneal Dialysis, With Steven Brunelli, MD

42% on Povetacicept Reach KDIGO-Aligned UPCR Target in RAINIER

RLS-1496 Cream Reduces Actinic Keratosis Lesions Mary Spellman, MD

Knowledge Hub

Tumor Metabolic Waste Products as Markers of Treatment Adaptation

Coordinating Supportive Care During Cancer Treatment Breaks

Pediatric Cancer Cell Line Authentication and Reproducibility

Case-Based Learning: Fever During Targeted Cancer Therapy Without Infection

Tumor Clonal Evolution Through Single-Cell Genomics

Mechanisms of Tumor Metabolic Plasticity During Nutrient Stress

RNA Vaccines for Therapeutic Oncology: Mechanisms, Clinical Applications, and Future Directions

KOL Videos

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part IV

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part III

An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Conclusion

Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part II

An In-Depth Look At The Signs And Symptoms Of Lymphoma- Further Discussion

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Current Scenario of Cancer- Q&A Session to Close the Gap Part II

Quick Links

Verification

Welcome to Hidoc Dr.

Page Views